Synthesis and antitumor activity of new silver(I)-N-heterocyclic carbene complexes

Abstract

In this study, two novel benzimidazole-based N-heterocyclic carbene ligands (1a-b) and their silver(I) complexes (2a-b) were synthesized. All new compounds were characterized by FT-IR, LC-MS, ¹H NMR, and ¹³C NMR spectroscopies. The in vitro antitumor activities of NHC ligands (1a-b) and their silver(I) complexes (2a-b) against DU-145 human prostate cancer cells, MDA-MB-231 and MCF-7 human breast cancer cells and L-929 (normal cells adipose from mouse) were also determined using MTT analysis for 24?h, 48?h, and 72?h. The results showed that while NHC ligands did not have in vitro antitumor activity on MCF-7, MDA-MB-231 and DU-145 cells, Ag(I)-NHC complexes have in vitro antitumor activities. The in vitro antitumor activity of 2a was found to be lower than that of 2b. Ag(I)-NHC complexes were observed to have higher IC₅₀ values for non-cancerous cell lines than cancer cells.     

Some new Cu(II) complexes containing an ON donor Schiff base: Synthesis, characterization and antibacterial activity

Six new copper(II) complexes, CuLCl·H₂O (1), CuL(NO₃)·2H₂O (2), [Cu(L)₂] (3), CuL(SCN)·2H₂O (4), CuL(ClO₄)·2H₂O (5) and (CuL)₂(SO₄)·4H₂O (6), where HL = 1-phenyl-2,3-dimethyl-4-(N-2-hydroxy-4-methoxy-benzaldehyde)-3-pyrazolin-5-one, have been synthesized. The characterization of the newly formed compounds was done by ¹H NMR, UV-Vis, IR, ESR spectroscopy, elemental analysis and molar electric conductivity. The crystal structure of 1-phenyl-2,3-dimethyl-4-(N-2-hydroxy-4-methoxy-benzaldehyde)-3-pyrazolin-5-one has been determined by X-ray diffraction studies, as well as the crystal structure of one of its copper(II) complexes, [Cu(L)₂] (3). The copper atom is coordinated to two nitrogen and two oxygen atoms of the Schiff base ligand. The in vitro antibacterial activity against Klebsiella pneumoniae ATCC 100131, Staphylococcus aureus var. Oxford 6538, Pseudomonas aeruginosa ATCC 9027 and Escherichia coli ATCC 10536 strains was studied and compared with that of free ligand. The anti-microbial activity was dependent on the microbial species tested and the metal salt anion used.     

(E)-1-氯-6,6-二甲基-2-庚烯-4-炔的立体选择性合成

(E)-1-氯-6,6-二甲基-2-庚烯-4-炔是合成盐酸特比萘芬的关键中间体,N-氯代二异丙胺/三苯基膦与6,6-二甲基-1-庚烯-4-炔-3-醇反应,可以立体选择性地得到反式的该化合物,其反式/顺式异构体的比例达9/1,为特比萘芬提供了可工业放大生产的立体选择性合成方法。     

2-(2-(Dimethylamino)vinyl)-4H-pyran-4-ones as Novel and Convenient Building-Blocks for the Synthesis of Conjugated 4-Pyrone Derivatives

A straightforward approach for the construction of the new class of conjugated pyrans based on enamination of 2-methyl-4-pyrones with DMF-DMA was developed. 2-(2-(Dimethylamino)vinyl)-4-pyrones are highly reactive substrates that undergo 1,6-conjugate addition/elimination or 1,3-dipolar cycloaddition/elimination followed by substitution of the dimethylamino group without ring opening. This strategy includes selective transformations leading to conjugated and isoxazolyl-substituted 4-pyrone structures. The photophysical properties of the prepared 4-pyrones were determined in view of further design of novel merocyanine fluorophores. A solvatochromism was found for enamino-substituted 4-pyrones accompanied by a strong increase in fluorescence intensity in alcohols. The prepared conjugated structures demonstrated valuable photophysical properties, such as a large Stokes shift (up to 204 nm) and a good quantum yield (up to 28%).     

4-对丙烯基苯氨基喹唑啉衍生物的合成及抗肿瘤活性研究

以3-羟基苯甲腈为原料,经过6步反应(醚化、硝化、还原、甲脒的形成、环化和取代)合成了两个新型4-对丙烯基苯氨基喹唑啉衍生物4-[4-(E)-丙烯基苯氨基]-6-[2-吗啉基乙氧基]喹唑啉和4-[4-(E)-丙烯基苯氨基]-6-[3-吗啉基丙氧基]喹唑啉。化合物的结构经IR、HRMS、1H NMR和13C NMR确认。以人结肠癌细胞(SW480)、人肺癌细胞(A549)、人皮肤鳞状细胞癌细胞(A431)为模型,采用MTT法对所得化合物进行了体外抗肿瘤活性评价。结果表明,两个化合物均具有一定的抗肿瘤活性。特别是化合物4-[4-(E)-丙烯基苯氨基]-6-[3-吗啉基丙氧基]喹唑啉对所试肿瘤细胞均表现出良好的生长抑制活性(IC50:10.0~18.2μmol/L),与临床使用药物吉非替尼的活性(IC50:4.1~18.5μmol/L)相当。     

(S)-6-苄氧基-5-羟基-3-氧代-己酸叔丁酯合成新方法

研究了一条新的路线用于(S)-6-苄氧基-5-羟基-3-氧代-己酸叔丁酯的合成. 以廉价、易得的R-环氧氯丙烷为起始原料, 经过几步比较温和的反应得到目标化合物. 在此基础上, 通过对催化剂三氟化硼乙醚用量的考察以及两条反应路线优缺点的比较, 找到了一条适合大规模制备的工艺路线. 该路线具有收率高、原料易得、反应条件温和、产物容易分离、提纯等特点.     

Synthesis of (4R)-Methylnonan-1-ol and (4R,8RS)-Dimethyldecanal from (S)-(+)-3,7-Dimethyl-1,6-octadiene

Optically active (4R,8RS)-dimethyldecanal, an analog of the aggregation pheromone of the flour beetles Tribolium confusum and T. Castaneum, and (4R)-methylnonan-1-ol, the sex pheromone of the yellow mealworm Tenebrio molitor L., are synthesized using ozonolytic transformation of (6R,10)-dimethyl-9-undecen-2-one to (6R)-methyl-9-hydroxynonan-2-one in the key step. The starting compound is available as enantiomerically enriched (ee ~50%) (S)-(+)-3,7-dimethyl-1,6-octadiene.     

利用工业废弃物中获得的(R)-5-甲基-δ-戊酸内酯为原料合成(2R,6R)-2,6,10-三甲基十一醇

(2R,6R)-2,6,10-三甲基十一醇(1)是维生素E、维生素K和植醇的基本结构单元. 利用从甾体皂甙元氧化降解产生的工业废弃物中所获得的手性化合物(R)-5-甲基-δ-戊酸内酯(6), 先将其转化成为化学性质稳定的(4R)-甲基-5-甲氧甲氧基戊酸甲酯(7), 再经十二步反应, 以14.1%的总收率合成得到了目标化合物(2R,6R)-2,6,10-三甲基十一醇(1).     

Synthesis and in vitro antitumor activity of phthalimide polymers containing podophyllotoxin

Polymer-linked PT (podophyllotoxin) conjugates have been designed to improve the therapeutic efficacy of PT. A new PT-conjugate, 3,6-endo-methylene-1,2,3,6-tetrahydrophthalimido-acetamidoglycinylglycine podophyllotoxin ester (ETPA-gly-gly-PT), was synthesized by covalently coupling its hydroxyl group onto the phthalimido monomer through a glycine-glycine-glycine spacer. Its homo- and copolymer with acrylic acid (AA) were prepared by photopolymerization using 2,2-dimethoxy-2-phenylacetophenone (DMP) as a photoinitiator. ETPA-gly-gly-PT and its polymers were characterized by IR and proton NMR spectra. The ETPA-gly-gly-PT content in the copolymer obtained by elemental analysis was 44 wt%. The number-average molecular weights of the polymers determined by gel permeation chromatography were as follows: M_n = 13,500 for poly(ETPA-gly-gly-PT), M_n = 17,000 for poly(ETPA-gly-gly-PT-co-AA). The in vitro antitumor activity of these conjugates and polymers were determined and used to evaluate the potential applications in antitumor drugs. The IC₅₀ values indicated that the synthesized ETPA-gly-gly-PT and its polymers against cancer cells were much better inhibitors than PT.     

Synthesis,characterization, and biological activity of new mixed ammine/amine platinum(IV) complexes

A series of mixed ammine/amine platinum(IV) complexes with lipophilic ligands in their axial positions were designed, synthesized, and spectrally characterized. In vitro cytotoxicity evaluation of these complexes and their lead compounds have been carried out against A549, SMMC-7721, MCF-7, and SW480 human cancer cell lines. The introduction of carboxylate ions as leaving group can improve the aqueous solubility and stability of the platinum(II) complexes. The carboxylato ligands and chloride ligands in the axial position markedly increased the lipophilicity and cytotoxicity of compounds C4 and C5. Particularly, compound C5 showed two to eight times higher cytotoxicity than cisplatin and satraplatin against selected cell lines. For its oral activity and no cross-resistance potentiality, C5 is expected to be an antitumor platinum drug candidate. This novel class of platinum compounds represents a valuable lead in the development of new-generation agents capable of demonstrating cytotoxicity superior to that of the clinically established cisplatin.     

Synthesis and antitumor activity of some new pyrazolo[1,5-a] pyrimidines

New series of pyrazolo[1,5-a]pyrimidine derivatives 7a-i, 11a-c and Schiff bases 13a-c were synthesized and screened for their in vitro antitumor activity against three human carcinoma cell lines, namely colorectal carcinoma (HCT116), prostate adenocarcinoma (PC-3) and liver carcinoma (HepG-2) using MTT cytotoxicity assay at 100 μg/mL. Some of the tested compounds displayed good anticancer activities against HCT-116 and PC-3 cells. Whereas, compounds 7d and 11a showed better antitumor activity than the rest of the compounds against both cell lines. A structure-activity relationship (SAR) has been discussed and structures of the newly synthesized compounds were confirmed by different spectral data (MS, IR, ¹H NMR and ¹³C NMR) and elemental analysis.     

Nucleophilic addition of arylmethylzinc reagents (ArCH2ZnCl) to formaldehyde: An easy access to 2-(hetro)arylethyl alcohols

The selective addition of arylmethylmagnesium halides with formaldehyde giving arylethyl alcohols is extremely challenging. To circumvent the difficulties, in the current communication, we have reported on the nucleophilic addition of benzyl zinc reagents derived from inexpensive and abundant benzyl chlorides to paraformaldehyde. The reaction investigated herein is hitherto unknown and was found to be selective, operationally simple, atom- and step-economical and high yielding to deliver phenethyl alcohols utilized as key perfumery ingredients in 60–83% yields. After successful establishment of the reaction condition, the reaction was also scaled up successfully to deliver a large-scale preparation of the phenethyl alcohol.     

Dimethylheptyl [3-(N-hetaryl)propyl]silanes: Synthesis,antimicrobial and antiblastic activity

The alkylation of monoazoles, diazoles, triazoles and tetrazoles with dimethylheptyl(3-iodopropyl)silane using liquid/liquid phase-transfer catalysis affords the corresponding [3-(N-azolyl)propyl]silanes in high yield, by which means the nonsymmetric ambident heterocycles 1,2,4-triazole and tetrazole undergo alkylation regiospecifically in position 1 and 2, respectively. Dimethylheptyl[3-(N-imidazolyl)propyl]silane demonstrated high fungistatic activity with respect to S. cerevisiae and T.rubrum in combination with high cytotoxicity.     

Synthesis, structure, and biological activity of mixed-ligand platinum(II) complexes with aminonitroxides

Mixed-ligand platinum complexescis-Pt^II(R⁶NH₂)(NH₃)X₂ andcis-Pt^II(R⁵NH₂)(NH₃)X₂ (R⁶ is 2,2,6,6-tetramethyl-4-piperidyl-1-oxyl and R⁵ is 2,2,5,5-tetramethyl-3-pyrrolidinyl-1-oxyl) were synthesized by either the reaction of aminonitroxides RNH₂ with Na[Pt^II(NH₃)Cl₂I] generatedin situ (for X₂=ClI) or by replacement of the iodo-chloro ligands incis-Pt¹¹(RNH₂)(NH₃)ClI by dichloro and oxalato ligands. The complexes obtained were characterized by elemental analysis and by IR, UV, and ESR spectra. Forcis-Pt¹¹(R⁵NH₂)(NH₃)Cl₂, crystal and molecular structures were determined by X-ray diffraction analysis. Cisplatin accelerates autooxidation of methyl linoleate and the platinum nitroxide complexes synthesized exhibit antioxidant properties. The rate of isolated DNA binding with the new complexes is almost as high as that for cisplatin.cis-Pt¹¹(R⁶NH₂)(NH₃)Cl₂ exhibits the highest antitumor activity. The high antitumor activity of platinum nitroxide complexes shows that the possible “radical component” is not a crucial factor in the cytotoxic action of cisplatin. Published inIzvestiya Akademii Nauk. Seriya Khimicheskaya, No. 9, pp. 1624–1630, September, 2000.     

Novel antitumor dinuclear platinum (II) complexes with a new chiral tetradentate ligand as the carrier group

Seven dinuclear platinum(II) complexes with a novel chiral tetradentate ligand, (1R,1′R,2R,2′R)‐N¹,N^1′‐(1,4‐phenylenebis(methylene))dicyclohexane‐1,2‐diamine, were designed, synthesized and spectrally characterized. All the complexes were evaluated for their in vitro cytotoxicity against human HepG‐2, A549, HCT‐116 and MCF‐7 cancer cell lines. The results indicated that all compounds showed positive biological activity against HepG‐2, A549 and HCT‐116 cancer cell lines. In particular, compounds D7 and D2 showed better activity than carboplatin against HepG‐2 and A549 and compound D7 also showed an activity close to that of oxaliplatin. Copyright © 2015 John Wiley & Sons, Ltd.     

Synthesis of new polyfunctional 2-pyrrolidinones from methyl 2-(carboethoxyhydroxymethyl)acrylate

The synthesis of new polyfunctional 2-pyrrolidinone derivatives from methyl 2-(carboethoxyhydroxymethyl)acrylate is described. These alkenes present an extremely high reactivity upon Michael addition with primary amines leading to a simple, mild, and efficient route to the preparation of new polyfunctional pyrrolidinones.     

Synthesis,characterization and antitumor activity of palladium(II) complexes of monoethyl 8-quinolylmethylphosphonate

The complex-forming properties of monoethyl 8-quinolylmethylphosphonate (8-Hmqmp) towards palladium(II) ion have been investigated by reactions of the hydrochloride, 8-Hmqmp · HCl · H₂O, and sodium salt, Na(8-mqmp) · 2H₂O, of this monoester with palladium(II) halide compounds in aqueous solution over a wide pH range. Depending on pH and initial quinolinium and palladium salts, four types of complexes have been formed. Under acidic solution the ion-pair salt complexes [8-H₂mqmp]₂[PdX₄] (1 and 2, pH < 3) and [8-H₂mqmp]₂[Pd₂X₆] (3 and 4, pH ∼ 3), with protonated quinoline ligand as cation and tetrahalopalladate or hexahalodipalladate complex as anion (X = Cl, Br), were isolated. By heating in methanol the chloro complexes 1 and 3 as well as bromo complexes 2 and 4 were converted into the quinolinium salt complexes, [8-H₂mqmp][Pd(8-Hmqmp)X₃], 5 and 6, respectively, containing as anion the quinoliniummethylphosphonatetrihalopalladate complex with palladium bonded at the phosphonic acid moiety. The chelate complex 7, [Pd(8-mqmp)₂], with ligand bonded through the quinoline nitrogen and the deprotonated phosphonic acid oxygen and forming two seven-membered {N,O} chelate rings, was obtained in neutral and basic media. The complexes were identified and characterized by elemental analysis, magnetic and conductance measurements, spectroscopic studies (IR, ¹H NMR, UV–Vis, positive/negative ion FAB MS) and thermal analysis (TG, DTA). As a preliminary screening for their biological activity, complexes were investigated for their ability to inhibit the cancer growth in vitro in the human KB and murine L1210 cell lines. The results obtained were compared with those obtained for the complexes of diethyl 8-quinolylmethylphosphonate (8-dqmp) and monoethyl 2-quinolylmethylphosphonate (2-Hmqmp), and structural factors that determine the complex activity were discussed.     

Synthesis and Biological Activity of 3-(Heteroaryl)quinolin-2(1H)-ones Bis-Heterocycles as Potential Inhibitors of the Protein Folding Machinery Hsp90

In the context of our SAR study concerning 6BrCaQ analogues as C-terminal Hsp90 inhibitors, we designed and synthesized a novel series of 3-(heteroaryl)quinolin-2(1H), of types 3, 4, and 5, as a novel class of analogues. A Pd-catalyzed Liebeskind–Srogl cross-coupling was developed as a convenient approach for easy access to complex purine architectures. This series of analogues showed a promising biological effect against MDA-MB231 and PC-3 cancer cell lines. This study led to the identification of the best compounds, 3b (IC₅₀ = 28 µM) and 4e, which induce a significant decrease of CDK-1 client protein and stabilize the levels of Hsp90 and Hsp70 without triggering the HSR response.     

Synthesis,characterization of diorganotin (IV) schiff base complexes and their in vitro antitumor activity

Six novel diorganotin(IV) complexes have been synthesized in good yields by the reaction of R₂SnCl₂ (R= methyl, phenyl) with the Schiff base derived from salicylaldehyde and substituted thiosemicarbazide. The complexes were characterized by elemental analysis, IR, ¹H NMR and MS spectra. The structure of 2f was confirmed by single crystal X‐ray diffraction. The crystal of 2f is triclinic, space group P‐1 with a = 0.84996(12), b = 1.1204(2), c = 1.27597(12) nm, β = 81.908(9)°, V=1.0904(2) nm³, Z = 2, D_c= 1.551 g/cm³. The final discrepancy factors are R = 0.0211 and R_w = 0.0536 for 3710 independent reflections. Tests of antitumor activities in vitro showed that the obtained complexes had relative inhibition interaction to the KB, HCT‐8 and BEL‐7402 tumor cell lines.